2023 annual financial data
NovoCure 2023 Operating margin
Direct answer
Operating margin was -45.72%.
Operating income was -232,870,000 USD and net income was -207,043,000 USD.
Operating cash flow was -73,336,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 509,338,000 USD
- Operating income
- -232,870,000 USD
- Net income
- -207,043,000 USD
- Operating cash flow
- -73,336,000 USD